June 19, 2024

Automated Breast Ultrasound Systems Market Size, Trends, Report 2033

The global automated breast ultrasound systems market size was valued at USD 2.31 billion in 2023 and is projected to hit around USD 9.84 billion by 2033 with a CAGR of 15.59% from 2024 to 2033.

Automated Breast Ultrasound Systems Market Size 2024 to 2033

Key Points

  • North America dominated the automated breast ultrasound systems market with the largest share in 2023.
  • Asia Pacific is observed to witness the fastest rate of growth during the forecast period.
  • By product, the automated breast ultrasound scanner segment has contributed the largest market share of in 2023.
  • By product, the automated breast volume scanner combination therapy segment is observed to witness a notable rate of growth during the forecast period.
  • By end user, the radiologists segment dominated the market in 2023.
  • By end user, the surgeon segment is projected to witness rapid growth in the upcoming years.

The Automated Breast Ultrasound Systems (ABUS) market is witnessing significant growth due to advancements in breast cancer screening technologies and rising awareness about the importance of early detection. ABUS offers several advantages over traditional mammography, including improved accuracy in dense breast tissue imaging and reduced operator dependency. As a result, healthcare providers and patients are increasingly adopting ABUS systems, leading to a surge in market demand.

Get a Sample: https://www.precedenceresearch.com/sample/3925

Growth Factors

Several factors are driving the growth of the Automated Breast Ultrasound Systems market. Firstly, the increasing incidence of breast cancer worldwide has heightened the need for more effective screening tools. ABUS provides additional diagnostic information, particularly for women with dense breast tissue, enhancing early detection rates and improving patient outcomes. Additionally, technological advancements in ABUS systems, such as improved image resolution and automated image acquisition, are enhancing the efficiency and accuracy of breast cancer diagnosis, further fueling market growth.

Region Insights:

The demand for Automated Breast Ultrasound Systems varies across different regions, influenced by factors such as healthcare infrastructure, regulatory environment, and awareness levels. Developed regions like North America and Europe dominate the ABUS market, driven by a high prevalence of breast cancer, well-established healthcare systems, and favorable reimbursement policies. In contrast, emerging economies in Asia-Pacific and Latin America are witnessing rapid market growth due to increasing healthcare expenditure, improving access to medical services, and rising awareness about breast cancer screening.

Automated Breast Ultrasound Systems Market Scope

Report CoverageDetails
Growth Rate from 2024 to 2033CAGR of 15.59%
Global Market Size in 2023USD 2.31 Billion
Global Market Size by 2033USD 9.84 Billion
Largest MarketNorth America
Base Year2023
Forecast Period2024 to 2033
Segments CoveredBy Product and By End-user
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Automated Breast Ultrasound Systems Market Dynamics

Drivers:

Several drivers are contributing to the growth of the Automated Breast Ultrasound Systems market. One key driver is the growing emphasis on personalized medicine and preventive healthcare, leading to increased demand for advanced screening technologies like ABUS. Moreover, government initiatives and awareness campaigns promoting breast cancer screening and early detection are driving market growth globally. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms into ABUS systems is enhancing diagnostic accuracy and efficiency, further propelling market expansion.

Opportunities:

The Automated Breast Ultrasound Systems market presents numerous opportunities for manufacturers, healthcare providers, and investors. Expanding into untapped markets, particularly in emerging economies with growing healthcare infrastructure, offers significant growth prospects. Moreover, technological innovations, such as the development of portable and handheld ABUS devices, can expand the reach of breast cancer screening services, especially in remote and underserved areas. Furthermore, collaborations between healthcare organizations and technology companies for research and development initiatives can lead to the introduction of novel ABUS solutions, creating new opportunities in the market.

Challenges:

Despite the promising growth prospects, the Automated Breast Ultrasound Systems market faces several challenges. One major challenge is the high cost associated with ABUS systems, limiting their accessibility, particularly in low-income regions. Moreover, regulatory hurdles and reimbursement constraints in certain countries may hinder market expansion. Additionally, the lack of trained healthcare professionals proficient in interpreting ABUS images poses a challenge to widespread adoption. Addressing these challenges requires concerted efforts from industry stakeholders, policymakers, and healthcare organizations to ensure equitable access to ABUS technologies and improve diagnostic capabilities globally.

Read Also: Acne Medication Market Size to Hit USD 19.17 Bn by 2033

Recent Developments

  • In February 2024, Butterfly Network introduced the iQ3TM handheld ultrasound system, incorporating advanced image processing, artificial intelligence (AI) capabilities, and enhanced 3D imaging technology. This innovative device marks a significant milestone in ultrasound technology, offering healthcare professionals a portable and powerful tool for diagnostic imaging with improved accuracy and efficiency.
  • In October 2023, Philips Healthcare unveiled a groundbreaking solution for breast ultrasound imaging, combining hardware and software into a cohesive package. Available on the company’s Epiq and Affiniti ultrasound scanners, this innovative offering integrates Philips’ PureWave eL18-4 ultra-broadband linear-array transducer with advanced ‘anatomical intelligence’ automated software.

Automated Breast Ultrasound Systems Market Companies

  • ALPINION Medical Systems Co., Ltd.
  • BK Medical Holding Company, Inc.
  • Canon Medical Systems Corporation
  • Delphinus Medical Technologies, Inc.
  • Fukuda Denshi Co., Ltd.
  • GE Healthcare
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • QT Imaging, Inc.
  • Samsung Group
  • Seno Medical Instruments, Inc.
  • Siemens Healthineers AG
  • SonoCine, Inc.

Segments Covered in the Report

By Product

  • Automated Breast Ultrasound System
  • Automated Breast Volume Scanner
  • Automated Breast Ultrasound Device
  • Automated Breast Imaging System
  • Automated Breast Ultrasound Scanner
  • Automated Breast Ultrasound Equipment
  • Automated Breast Ultrasound Machine
  • Automated Breast Ultrasound Technology

By End-user

  • Radiologists
  • Oncologists
  • Breast Surgeons
  • Gynecologists
  • Breast Imaging Technologists
  • Healthcare Providers
  • Patients

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/